{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:12:29Z","timestamp":1793967149735,"version":"4.8.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"41","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiogenic shock (CS) is a state of acute circulatory failure resulting from impaired myocardial function and reduced cardiac output, leading to inadequate tissue perfusion and subsequent organ dysfunction. In its early phase, CS is typically accompanied by systemic vasoconstriction as a compensatory response aimed at preserving mean arterial pressure and organ perfusion. However, an increasing body of evidence suggests that a subset of patients develop a mixed shock phenotype, characterized by superimposed vasodilation without evidence of concurrent sepsis, which portends a worse prognosis. Failure of the renin-angiotensin-aldosterone system (RAAS) may be a key driver of pathological vasodilation in CS, analogous to recent observations in septic shock. Specifically, RAAS dysfunction could lead to impaired angiotensin II signalling at the angiotensin II type 1 receptor level due to defective angiotensin II generation, enhanced peptide degradation, and\/or receptor unavailability. Recognition of RAAS failure in CS could inform novel therapeutic strategies to restore vascular tone and improve outcomes in patients with mixed cardiogenic-vasodilatory shock.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehag292","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:45:28Z","timestamp":1775735128000},"page":"6161-6165","source":"Crossref","is-referenced-by-count":1,"title":["Renin-angiotensin-aldosterone system failure drives inappropriate vasodilation in cardiogenic shock: a hypothesis"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0639-5598","authenticated-orcid":false,"given":"Adrien","family":"Picod","sequence":"first","affiliation":[{"name":"Medical-Surgical Intensive Care Unit, University Hospital Avicenne, AP-HP , 125 rue de Stalingrad, 93000 Bobigny ,","place":["France"]},{"name":"INSERM UMR-S 942 MASCOT\u2014Universit\u00e9 Paris\u2014Cit\u00e9 , H\u00f4pital Lariboisi\u00e8re\u2014P\u00f4le Viggo Petersen, 2, rue Ambroise Par\u00e9, 75465 Paris Cedex 10 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6425-3360","authenticated-orcid":false,"given":"Susanna","family":"Price","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital Adult Intensive Care Unit, , London ,","place":["UK"]},{"name":"National Heart & Lung Institute, Imperial College , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hanff","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Utah School of Medicine , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2026110518532143700_ehag292-B1","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele","year":"2019","journal-title":"Eur Heart J"},{"key":"2026110518532143700_ehag292-B2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1161\/CIRCULATIONAHA.124.069508","article-title":"Mixed cardiogenic shock: a proposal for standardized classification, a hemodynamic definition, and framework for management","volume":"150","author":"van Diepen","year":"2024","journal-title":"Circulation"},{"key":"2026110518532143700_ehag292-B3","doi-asserted-by":"publisher","first-page":"e011404","DOI":"10.1161\/CIRCHEARTFAILURE.123.011404","article-title":"Mixed shock complicating cardiogenic shock: frequency, predictors, and clinical outcomes","volume":"17","author":"Baldetti","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026110518532143700_ehag292-B4","doi-asserted-by":"publisher","first-page":"e011827","DOI":"10.1161\/CIRCHEARTFAILURE.124.011827","article-title":"Pathophysiologic vasodilation in cardiogenic shock and its impact on mortality","volume":"17","author":"Chavez","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026110518532143700_ehag292-B5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13613-024-01325-y","article-title":"Impaired angiotensin II signaling in septic shock","volume":"14","author":"Picod","year":"2024","journal-title":"Ann Intensive Care"},{"key":"2026110518532143700_ehag292-B6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.123.21913","article-title":"Circulating dipeptidyl peptidase 3 modulates systemic and renal hemodynamics through cleavage of angiotensin peptides","volume":"81","author":"Picod","year":"2024","journal-title":"Hypertens Dallas"},{"key":"2026110518532143700_ehag292-B7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJM198204223061617","article-title":"Plasma renin activity levels in two patients with impending cardiogenic shock","volume":"306","author":"Cunningham","year":"1982","journal-title":"N Engl J Med"},{"key":"2026110518532143700_ehag292-B8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1378\/chest.86.1.40","article-title":"Renin and the complications of acute myocardial infarction","volume":"86","author":"Vaney","year":"1984","journal-title":"Chest"},{"key":"2026110518532143700_ehag292-B9","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026110518532143700_ehag292-B10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ejhf.1600","article-title":"Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial","volume":"22","author":"Takagi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2026110518532143700_ehag292-B11","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.1016\/j.bja.2021.11.021","article-title":"High plasma dipeptidyl peptidase 3 levels are associated with mortality and organ failure in shock: results from the international, prospective and observational FROG-ICU cohort","volume":"128","author":"Deniau","year":"2022","journal-title":"Br J Anaesth"},{"key":"2026110518532143700_ehag292-B12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardfail.2024.03.014","article-title":"High circulating dipeptidyl peptidase 3 predicts mortality and need for organ support in cardiogenic shock: an ancillary analysis of the ACCOST-HH trial","volume":"31","author":"Picod","year":"2025","journal-title":"J Card Fail"},{"key":"2026110518532143700_ehag292-B13","doi-asserted-by":"publisher","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/41\/6161\/68281234\/ehag292.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/41\/6161\/68281234\/ehag292.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:53:27Z","timestamp":1793922807000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/41\/6161\/8677666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":13,"journal-issue":{"issue":"41","published-online":{"date-parts":[[2026,5,13]]},"published-print":{"date-parts":[[2026,11,6]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag292","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11,1]]},"published":{"date-parts":[[2026,5,13]]}}}